Women with polycystic ovary syndrome (PCOS) in their reproductive years age present with metabolic dysfunction and thus increased likelihood of long-term health consequences and diminished well-being in later life. Due to their larger ovarian reserve, however, they may experience menopause at later age and protection from metabolic and cardiovascular diseases. Moreover, previous studies have indicated that late reproductive aged, normal-weight women with PCOS do not seem to have the expected high risk for type 2 diabetes (T2D), as previously thought. Health related quality of life (HRQoL), nevertheless, is decreased in women with PCOS up until late fertile age, warranting attention and actions from the health care personnel. Given conflicting reports regarding the risk of cardiovascular diseases, future research with well characterized and adequately sized PCOS populations are needed as well as studies aiming to improve their HRQoL.
|Tidskrift||Current opinion in endocrine and metabolic research|
|Status||Publicerad - 28 feb 2020|
Citera det här
Ollila, M-M., Piltonen, T. T., Tapanainen, J. S., & Morin-Papunen, L. (2020). Ageing women with PCOS: Menstrual cycles, metabolic health and health related quality of life (HRQoL). Current opinion in endocrine and metabolic research. https://doi.org/10.1016/j.coemr.2020.02.010